Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can take levothyroxine with semaglutide, but the combination requires careful monitoring. Semaglutide slows gastric emptying, which can alter how quickly your gut absorbs levothyroxine — a medicine with a notoriously narrow therapeutic window — meaning your thyroid hormone levels may shift even if your dose hasn't changed. That's not a reason to avoid treatment, but it is a reason to have your thyroid function checked after starting. Both Wegovy and oral semaglutide are prescription-only medicines requiring clinical assessment before a prescriber can decide what's appropriate for you personally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Levothyroxine is one of the most precisely dosed medicines in common use. Your GP probably took several blood tests to land on your current dose, and even a modest change in absorption can tip you into symptoms of over- or under-treatment. That's worth taking seriously, and it's entirely fair to feel cautious about adding anything new to that balance.
Semaglutide (the active ingredient in Wegovy) works partly by slowing the rate at which your stomach empties. That's a big part of why it reduces appetite. But slowed gastric emptying doesn't just affect food, it affects oral medicines too. Levothyroxine is already known to have its absorption disrupted by food, coffee, calcium, and iron; a slower gut transit can add another variable to that picture.
The practical risk isn't that levothyroxine becomes ineffective. It's that the timing and rate of absorption may shift enough to alter your TSH reading, even with no change to your levothyroxine dose. Some people end up slightly under-replaced; a smaller number slightly over. The NHS medicines guidance on semaglutide notes that other medicines taken by mouth should be considered in the context of delayed gastric emptying, and if you want to go deeper on exactly how these two medicines interact, our page covering the semaglutide and levothyroxine interaction sets out the detail your prescriber and GP will want to know.
There is no blanket contraindication between semaglutide and levothyroxine. The Wegovy SmPC (the official prescribing document) acknowledges the gastric-emptying effect on oral medicines and advises that co-administered drugs with narrow therapeutic indices (levothyroxine sits squarely in that category) deserve particular attention and monitoring. The same principle applies across GLP-1 medicines more broadly.
What that means practically: if you're starting semaglutide while established on levothyroxine, a thyroid function test within a few months of starting is sensible. If your TSH drifts, your GP can adjust the levothyroxine dose rather than stopping the semaglutide. People on levothyroxine already tend to have regular blood tests, so in many cases the monitoring is already in the system, it just needs to be flagged.
One thing worth doing: take your levothyroxine at its usual time (typically first thing in the morning, at least 30 minutes before eating), keep that routine consistent, and mention the new medicine to whoever manages your thyroid condition. The full picture of semaglutide interactions is broader than this one drug, so a complete medicines review is worthwhile before you start.
If you're weighing up the cost of private weight-loss treatment alongside everything else, a breakdown of Wegovy pricing in the UK may be useful context.
A question our prescribers hear regularly: "Do I need to tell my GP I'm starting this?" If you're on levothyroxine, the answer is yes, and not just as a courtesy. GP notification is part of how responsible online prescribing works, and at nume it's built into the consultation process in line with GPhC guidance.
When you complete your consultation, list levothyroxine clearly in your medicines section. Include your current dose and how long you've been on it. If your thyroid condition is treated by an endocrinologist rather than your GP, mention that too, it helps our prescriber flag the right person for follow-up. A clinician reviews every consultation personally; the clinical team considers your full medicines list as part of that assessment, not just the weight-related indicators.
If any symptoms suggest your thyroid balance has shifted after starting semaglutide (unexpected fatigue, feeling cold, heart palpitations, weight changes in the wrong direction despite treatment) book a blood test with your GP promptly. Semaglutide does not affect the thyroid gland itself; what can change is levothyroxine absorption, and that's correctable with a dose adjustment. For a wider look at how semaglutide behaves over time in the body, the page on how semaglutide works across the week gives useful background.
If you'd like a prescriber to review your specific situation, including your levothyroxine dose and any other medicines you take, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.